Cardiotonic Agents

"Cardiotonic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).

Descriptor ID	D002316
MeSH Number(s)	D27.505.954.411.222 D27.720.799.080
Concept/Terms	Cardiotonic Agents Cardiotonic Agents Cardiac Stimulants Inotropic Agents, Positive Cardiac Cardiotonic Drugs Cardiotonics Myocardial Stimulants Cardioprotective Agents

Below are MeSH descriptors whose meaning is more general than "Cardiotonic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Cardiotonic Agents [D27.505.954.411.222]
Specialty Uses of Chemicals [D27.720]
Protective Agents [D27.720.799]
Cardiotonic Agents [D27.720.799.080]

Below are MeSH descriptors whose meaning is more specific than "Cardiotonic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiotonic Agents" by people in this website by year, and whether "Cardiotonic Agents" was a major or minor topic of these publications.

Bar chart showing 60 publications over 23 distinct years, with a maximum of 7 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	2	4
1997	2	0	2
1998	1	1	2
1999	0	2	2
2000	1	3	4
2001	1	0	1
2003	1	0	1
2004	2	3	5
2005	1	0	1
2006	1	1	2
2007	2	5	7
2008	0	1	1
2009	0	4	4
2010	3	2	5
2012	0	4	4
2014	2	2	4
2015	1	0	1
2016	1	1	2
2017	0	2	2
2018	1	0	1
2019	0	1	1
2020	2	1	3
2024	1	0	1

Below are the most recent publications written about "Cardiotonic Agents" by people in Profiles.

Maini M, Anderson KM, Seplowe M, Crowell NA, Pitcher C, Scally R, Weintraub WS, Najjar SS, Groninger H, Rao A. Disease-State Understanding and Experience of Patients Receiving Continuous Intravenous Inotropic Support as Palliative Therapy: A Multicenter Survey. J Palliat Med. 2024 08; 27(8):1026-1032.

View in: PubMed
Cruz Rodriguez JB, Stewart GC, Pamboukian SV, Tallaj JA, Rajapreyar I, Kirklin JK, Holman WL, Hoopes CW, Mukherjee D, Mallawaarachchi I, Dwivedi A, Acharya D. Clinical characteristics and outcomes of patients requiring prolonged inotropes after left ventricular assist device implantation. Artif Organs. 2020 Oct; 44(10):E382-E393.

View in: PubMed
McCulloch MA, Zuckerman WA, M?ller T, Knecht K, Lin KY, Beasley GS, Peng DM, Albert DC, Miera O, Dipchand AI, Kirk R, Davies RR. Effects of donor cause of death, ischemia time, inotrope exposure, troponin values, cardiopulmonary resuscitation, electrocardiographic and echocardiographic data on recipient outcomes: A review of the literature. Pediatr Transplant. 2020 05; 24(3):e13676.

View in: PubMed
Xie D, Zhao J, Guo R, Jiao L, Zhang Y, Lau WB, Lopez B, Christopher T, Gao E, Cao J, Ma X, Wang Y. Sevoflurane Pre-conditioning Ameliorates Diabetic Myocardial Ischemia/Reperfusion Injury Via Differential Regulation of p38 and ERK. Sci Rep. 2020 01 08; 10(1):23.

View in: PubMed
Barfuss SB, Butts R, Knecht KR, Prada-Ruiz A, Lal AK. Outcomes of Myocarditis in Patients with Normal Left Ventricular Systolic Function on Admission. Pediatr Cardiol. 2019 Aug; 40(6):1171-1174.

View in: PubMed
Woody MS, Greenberg MJ, Barua B, Winkelmann DA, Goldman YE, Ostap EM. Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working stroke. Nat Commun. 2018 09 21; 9(1):3838.

View in: PubMed
Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, Shah KB, Bruckner BA, Lee S, Long JW, Selzman CH, Kasirajan V, Haas DC, Boyle AJ, Chuang J, Farrar DJ, Rogers JG. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results. JACC Heart Fail. 2017 07; 5(7):518-527.

View in: PubMed
Mysliwiec M, Bonita RE. Outpatient Emergencies: Acute Heart Failure. Med Clin North Am. 2017 May; 101(3):507-519.

View in: PubMed
Agus MS, Hirshberg E, Srinivasan V, Faustino EV, Luckett PM, Curley MA, Alexander J, Asaro LA, Coughlin-Wells K, Duva D, French J, Hasbani N, Sisko MT, Soto-Rivera CL, Steil G, Wypij D, Nadkarni VM. Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children. Contemp Clin Trials. 2017 02; 53:178-187.

View in: PubMed
Foglia EE, Langeveld R, Heimall L, Deveney A, Ades A, Jensen EA, Nadkarni VM. Incidence, characteristics, and survival following cardiopulmonary resuscitation in the quaternary neonatal intensive care unit. Resuscitation. 2017 01; 110:32-36.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement